Pfizer Inc TRML Holdings History
Number of Shares
1.27 Mil
Current Holdings Value*
$19.35 Mil
% of Portfolio
3.86%
Total Estimate Gain
$-8.42 Mil
% of Total Estimate Gain
-26.31%
Pfizer Inc's Tourmaline Bio Inc Holding Summary
As of 2025-03-31, Pfizer Inc held 1.27 Mil shares of Tourmaline Bio Inc(TRML), totaling $19.35 Mil. This investment constitutes 3.86% of their stock portfolio, and Pfizer Inc now holds 4.95% of the outstanding Tourmaline Bio Inc(TRML) stock.
The initial trade took place in 2024Q4. Based on historical transaction data and TRML's current price of $18.54, Pfizer Inc's estimated gain on his TRML holdings is $-8.42 Mil, reflecting a -26.31% gain to date.
Pfizer Inc TRML ($18.54) Holding Chart
Pfizer Inc TRML ($18.54) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1